In the setting of systemic disease, it is postulated that various metabolic derangements underlie the pathophysiology of Kyrle disease. The fact that Kyrle disease also occurs in non-diabetic renal diseases suggests uremia, rather than hyperglycemia, as the causative factor in diabetic and renal failure patients.

In addition, serum and immunohistochemical studies have shown an increase in fibronectin levels and deposition, which may play a role in inciting epithelial migration and proliferation, leading to perforation.